Information  X 
Enter a valid email address

Legendary Invest PLC (LEG)

  Print      Mail a friend

Friday 02 August, 2013

Legendary Invest PLC

Investee company update

RNS Number : 8761K
Legendary Investments PLC
02 August 2013
 



2 August 2013

Legendary Investments Plc

("Legendary")

 

Investee Company Update - Medgold Resources Corp. ("Medgold") Awarded the Boticas Exploration Licence in Northern Portugal

 

Legendary, proactive investment company, is pleased to report that its investee company, Medgold Resources Corp. (TSX-V: MED), the European focused gold exploration company, has been awarded the Boticas exploration licence in Northern Portugal by the Direcao-Geral de Energia e Geologia of Portugal. 

 

Zafar Karim, Executive Chairman of Legendary commented:

"We're pleased that the Boticas licence has been awarded to Medgold. Medgold now plans to fast-track to resource definition and explore the wider licence area where there are several untested gold anomalies."

 

Further details are available at:

http://www.medgoldresources.com/images/content/Aug1.pdf 

For further information, please contact:

Contact:



Legendary Investments Plc

Zafar Karim / Thomas Reuner

 

020 8201 3536

Grant Thornton UK LLP

 

Colin Aaronson/ Melanie Frean / Jen Clarke

 

020 7383 5100

SI Capital                

 

Nick Emerson/ Andrew Thacker

01483 413500

Newgate Threadneedle

Caroline Evans-Jones

020 7653 9850

 

 

About Legendary Investments Plc

 

Legendary is a proactive investment company that focuses on making investments in and assisting companies which exhibit the potential to generate returns of many multiples through capital appreciation.  Typically, Legendary invests in small companies where there are clear catalysts for value appreciation and the companies are operating in sectors exhibiting long term growth. Examples of such sectors include technology, energy, natural resources and mining. Legendary is incorporated in the UK, which is its principal country of operation.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSAFDEFDSELA

a d v e r t i s e m e n t